Aspirin Efficacy in Primary Prevention: A Meta-analysis of Randomized Controlled Trials-Reference-Cited by-同舟云学术

Aspirin Efficacy in Primary Prevention: A Meta-analysis of Randomized Controlled Trials

Published:2019-07-06 Issue:4 Volume:26 Page:283-291
ISSN:1120-9879
Container-title:High Blood Pressure & Cardiovascular Prevention
language:en
Short-container-title:High Blood Press Cardiovasc Prev

Author:

Barbarawi Mahmoud^ORCID,Kheiri Babikir,Zayed Yazan,Gakhal Inderdeep,Al-Abdouh Ahmad,Barbarawi Owais,Rashdan Laith,Rizk Fatima,Bachuwa Ghassan,Alkotob Mohammad Luay

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s40292-019-00325-5.pdf

Reference27 articles.

1. Wenger NK. Prevention of cardiovascular disease: highlights for the clinician of the 2013 American College of Cardiology/American Heart Association guidelines. Clin Cardiol. 2014;37:239–51.

2. Gupta P, Gossett JM, Kofos D, Rettiganti M. Creation of an empiric tool to predict ECMO deployment in pediatric respiratory or cardiac failure. J Crit Care. 2018;49:21–6.

3. Ridker PM. Should aspirin be used for primary prevention in the post-statin era? N Engl J Med. 2018;379:1572–4.

4. Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet (London, England). 2009;373:1849–60.

5. Ogawa H, Nakayama M, Morimoto T, Uemura S, Kanauchi M, Doi N, et al. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. JAMA. 2008;300:2134–41.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Key Mutant Genes and Biological Pathways Involved in Aspirin Resistance in the Residents of the Chinese Plateau Area;Combinatorial Chemistry & High Throughput Screening;2024-03

2. Aspirin in primary cardiovascular prevention: the two faces of the coin and the importance of the Number Needed to Treat: a systematic review and meta-analysis.;Investigación Clínica;2023-08-28

3. Aspirin in primary cardiovascular prevention: the two faces of the coin and the importance of the Number Needed to Treat: a systematic review and meta-analysis.;INVEST CLIN;2023

4. Evaluation of anticoagulant and inflammatory effects of Tanacetum parthenium (L.) in a randomized controlled clinical trial;Journal of Herbal Medicine;2022-12

5. The protective effect of rivaroxaban with or without aspirin on inflammation, oxidative stress, and platelet reactivity in isoproterenol-induced cardiac injury in rats;Naunyn-Schmiedeberg's Archives of Pharmacology;2022-11-05